CCM Biosciences - Crunchbase Company Profile & Funding

Q: When was the last funding round for CCM Biosciences?

CCM Biosciences closed its last funding round on obfuscated from a Series A round.

Q: How much funding has CCM Biosciences raised to date?

CCM Biosciences has raised obfuscated.

Overview

CCM Biosciences

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About CCM Biosciences

CB Rank

52330

CCM Biosciences operates as a biopharmaceutical company that offers new drugs for medical conditions and diagnosis services.

Founded

obfuscation

Private

Series A

Mount Laurel, New Jersey, United States

ccm-bio.com/

Biopharma

Biotechnology

Medical

Funding Rounds

Series A

OBF

obfuscation

Key People

Raj Chakrabarti: Founder, Chairman and CEO
Anisha Ghosh: Co-Founder and Director of Portfolio

Details

Legal Name

CCM Biosciences, Inc.

Also Known As

CCM Bio

Operating Status

Active

Company Type

For Profit

Founders

Anisha Ghosh, Raj Chakrabarti

About the Company

CCM Biosciences operates as a biopharmaceutical company, that develops new drugs for different indications and associated companion diagnostic tests.

Contact Email

info@ccm-bio.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

CCM-848, 914, 930

Translational readthrough inducing drugs for cystic fibrosis and Duchenne muscular dystrophy, targeting nonsense mutations to upregulate protein expression.

CCM-SRX

Sirtuin activators targeting age-related diseases such as infertility, diabetes, neurodegenerative disorders, and cardiovascular diseases.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - CCM Biosciences	—	obfuscated obfuscation	—	Series A